SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 140 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $39,000 | +875.0% | 1,000 | +233.3% | 0.03% | +1000.0% |
| Q1 2015 | $4,000 | -42.9% | 300 | -40.0% | 0.00% | -40.0% |
| Q4 2014 | $7,000 | -92.1% | 500 | -88.1% | 0.01% | -90.0% |
| Q3 2014 | $89,000 | +20.3% | 4,200 | +68.0% | 0.05% | +22.0% |
| Q2 2014 | $74,000 | +208.3% | 2,500 | +150.0% | 0.04% | +156.2% |
| Q1 2014 | $24,000 | -22.6% | 1,000 | -33.3% | 0.02% | -11.1% |
| Q4 2013 | $31,000 | -34.0% | 1,500 | +50.0% | 0.02% | -35.7% |
| Q3 2013 | $47,000 | -17.5% | 1,000 | -33.3% | 0.03% | -30.0% |
| Q2 2013 | $57,000 | – | 1,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |